Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Health Care Down As Investors Retreat From Growth Sectors -- Health Care Roundup

09/04/2020 | 05:01pm EDT

Health-care companies fell as investors retreated from growth sectors, rotating into sectors that had not participated in the summer rally, such as financial and industrial companies.

A small Russian study of a Covid-19 vaccine showed promise with immune reactions, according to a paper published in prestigious British medical publication The Lancet.

Shares of Covid vaccine developer Moderna fell sharply after its chief executive said it was slowing down enrollment in the late-stage clinical trial vaccine to ensure diversity of the study's participants.

 

Write to Rob Curran at rob.curran@dowjones.com

All news about MODERNA, INC.
04/17MODERNA  : U.S. administers 205.9 mln doses of COVID-19 vaccines
RE
04/17U.S. PARENTS BEGIN TO ASK : Should my child get a COVID-19 shot?
RE
04/17Expat Americans Fly Home for Covid-19 Vaccination Shots
DJ
04/17MODERNA  : vaccine shipments to the UK delayed over supply chain concerns
AQ
04/16MODERNA  : B.C. health minister says delay in Moderna vaccine 'disappointing'
AQ
04/16Health Care Up After Strong Start to Earnings Season -- Health Care Roundup
DJ
04/16MODERNA  : U.S. administers 202.3 mln doses of COVID-19 vaccines - CDC
RE
04/16MODERNA  : U.S. CDC Says Delivered 258,502,815 Doses Of COVID-19 Vaccine As Of A..
RE
04/16Vaccine Manufacturing Issues Force Moderna to Cut Supplies to Canada, U.K.
DJ
04/16MODERNA  : sees shortfall in Britain COVID vaccine shipments, EU deliveries on t..
RE
More news
Financials (USD)
Sales 2021 17 046 M - -
Net income 2021 9 072 M - -
Net cash 2021 11 099 M - -
P/E ratio 2021 7,79x
Yield 2021 -
Capitalization 68 414 M 68 414 M -
EV / Sales 2021 3,36x
EV / Sales 2022 3,60x
Nbr of Employees 1 300
Free-Float 89,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 167,36 $
Last Close Price 170,81 $
Spread / Highest target 37,0%
Spread / Average Target -2,02%
Spread / Lowest Target -53,2%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.53.03%68 414
LONZA GROUP AG-1.83%45 120
IQVIA HOLDINGS INC.20.31%41 337
CELLTRION, INC.-14.21%37 693
SEAGEN INC.-16.92%26 380
INCYTE CORPORATION-4.35%18 177